San Mateo, CA, United States of America

Zahra Bahrami Dizicheh

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: 23Andme, Inc.. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Zahra Bahrami Dizicheh. Retrieved from https://idiyas.com/inventor/zahra-bahrami-dizicheh

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 13.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Zahra Bahrami Dizicheh: Innovator in Cancer Treatment

Introduction

Zahra Bahrami Dizicheh is a prominent inventor based in San Mateo, CA (US). She has made significant contributions to the field of cancer treatment through her innovative research and development of therapeutic proteins.

Latest Patents

Zahra holds a patent for Anti-ULBP6 antibodies. This patent relates to a ULBP6 binding protein that inhibits the interaction between ULBP6 and NKG2D. The methods described in her patent offer potential treatments for cancer using this ULBP6 binding protein.

Career Highlights

Zahra is currently employed at 23andMe, Inc., where she continues to advance her research in biotechnology and therapeutic applications. Her work is instrumental in developing new strategies for cancer treatment.

Collaborations

Zahra collaborates with notable colleagues, including Joel Benjamin and Shashank Bharill. These partnerships enhance her research efforts and contribute to the advancement of innovative solutions in the medical field.

Conclusion

Zahra Bahrami Dizicheh is a dedicated inventor whose work in developing Anti-ULBP6 antibodies showcases her commitment to improving cancer treatment. Her contributions to biotechnology are paving the way for future advancements in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…